Aduhelm’s ‘Complex’ Circumstances Drove Extensive In-House Advice Process Before Accelerated Approval, Cavazzoni Says

Accelerated approval was considered as option in response to the negative advisory committee vote, but it was not a ‘default,’ CDER officials say. ‘It fit like a glove.’

The US FDA eventually determined that accelerated approval eventually fit Aduhelm 'like a glove.' • Source: Alamy

More from Approvals

More from Product Reviews